Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$7,735,124
+$2,337,914 QoQ
Shares Held
6,449
+9.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#1,404
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CATALYST FINANCIAL PARTNERS LLC holds $23,806,391 across 9 Drug Manufacturers - General names. LLY ranks #1 (32.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,449 | $7,735,124 | |
| 2 | JNJ |
Johnson & Johnson
|
24,867 | $6,315,471 | |
| 3 | ABBV |
AbbVie Inc.
|
15,393 | $3,873,494 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,205 | $2,596,342 | |
| 5 | AMGN |
Amgen Inc
|
3,386 | $1,226,138 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,716 | $722,159 | |
| 7 | PFE |
Pfizer Inc
|
25,150 | $605,612 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,894 | $512,472 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,735,124 | 6,449 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $5,397,210 | 5,868 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,804,347 | 5,401 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $3,941,658 | 5,166 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,994,311 | 5,124 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,153,501 | 5,029 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,806,732 | 4,931 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,289,721 | 4,842 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $4,233,556 | 4,676 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $3,521,046 | 4,526 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,546,194 | 4,368 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $2,300,527 | 4,283 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,742,729 | 3,716 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,153,547 | 3,359 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $1,180,931 | 3,228 | Shares | Sole | 2023-01-19 | |
| No filing history on record for this holder in this stock. | ||||||